The global cell therapy manufacturing market will reach $ 6.01 billion by 2026

DUBLIN, September 13, 2022 / PRNewswire / – The “global market for cell therapy manufacturing, by therapy (T-cell therapies, dendritic cell therapies, cancer cell therapies, stem cell therapies), by cell source, by scale of operation, by source, by application, by end user, by region, competition forecast and opportunity, the 2026 report has been added “. by ResearchAndMarkets.com offer.

Research and Markets Logo

The global cell therapy manufacturing market has been assessed at 3,123.44 million dollars in the year 2020 and is expected to grow with a CAGR value of 12.0% over the forecast period, 2022-2026 to reach the market value of 6015.09 million dollars by 2026F. Market growth can be attributed to the advancement of biopharmaceutical industries around the world.

Furthermore, the growing reliance on cell therapy and therefore on therapeutic and pharmaceutical products for the efficient treatment of patients suffering from critical diseases and conditions is also supporting the growth of the global cell therapy manufacturing market over the next five years.

Furthermore, the increasing prevalence of chronic diseases such as cardiovascular disease, cancer diseases, along with lifestyle diseases such as obesity, diabetes which further deteriorates the immunity of human beings further contributes to the growth of the global therapy manufacturing market. mobile phones in the next five years.

Years considered for this report:

Objective of the study:

  • To analyze and estimate the market size of the global Cell Therapy Manufacturing market from 2016 to 2020.

  • Estimate and predict the market size of the global cell therapy manufacturing market from 2021 to 2026 and the growth rate to 2026.

  • Classify and predict the global Cell Therapy Manufacturing market based on therapy, cell source, operational scale, source, application, end user, company, and regional distribution.

  • To identify the dominant region or segment in the global cell therapy manufacturing market.

  • Identify the drivers and challenges for the global cell therapy manufacturing market.

  • To examine competitive developments such as expansions, new product launches, mergers and acquisitions, etc., in the global cell therapy manufacturing market.

  • Identify and analyze the profile of key players operating in the global cell therapy manufacturing market.

  • Identify key sustainable strategies adopted by market players in the global cell therapy manufacturing market.

Key target audience:

  • Manufacturers, suppliers, distributors and other interested parties

  • Government bodies such as regulators and policy makers

  • Organizations, forums and alliances related to cell therapy production

  • Market studies and consulting firms

The study is helpful in providing answers to several critical questions that are important to industry stakeholders such as manufacturers, suppliers, partners, end users, etc., as well as enabling them to devise investment strategies and capitalize on market opportunities.

Scope of the report:
In this report, the global Cell Therapy Manufacturing market has been segmented into the following categories, in addition to the industry trends which have been detailed below:

Global market for the production of cell therapies, by therapy

  • T cell therapies

  • Dendritic cell therapies

  • Cancer cell therapies

  • Stem cell therapies

Global Cell Therapy Manufacturing Market, By Cell Source

Global cell therapy manufacturing market, by scale of operation

  • Preclinical

  • Clinical

  • Commercial

Global Cell Therapy Manufacturing Market, By Source

  • In home

  • Contract manufacturing

Global Cell Therapy Manufacturing Market, By Application

  • Oncology

  • Cardiovascular disease

  • Orthopedic Diseases

  • Other

Global Cell Therapy Manufacturing Market, by End User

Global Cell Therapy Manufacturing Market, By Region

  • North America

  • United States

  • Canada

  • Mexico

  • Europe

  • Germany

  • France

  • United Kingdom

  • Spain

  • Italy

  • Asia-Pacific

  • China

  • Japan

  • South Korea

  • Australia

  • India

  • South America

  • Brazil

  • Argentina

  • Colombia

  • Middle East & Africa

  • Israel

  • South Africa

  • Saudi Arabia

  • United Arab Emirates

Key topics covered:

1. Product overview

2. Research methodology

3. Executive summary

4. Impact of COVID-19 on the global cell therapy manufacturing market

5. Voice of customers

6. Global market prospects for cell therapy production

7. Market prospects for cell therapy manufacturing in North America

8. Market prospects for cell therapy production in Europe

9. Outlook for the manufacturing market for Asia-Pacific cell therapies

10. Market prospects for cell therapy manufacturing in South America

11. Middle East and market prospects for cell therapy manufacturing in Africa

12. Market dynamics

13. Trends and market developments

14. Clinical trial

15. Patent analysis

16. Competitive landscape

17. Strategic recommendations

Companies mentioned

  • Novartis AG

  • F. Hoffmann La Roche AG

  • Gilead Sciences, Inc.

  • Thermo Fischer Scientific, Inc.

  • Catalent, Inc.

  • JSR Life Sciences LLC (KBI Biopharma Inc)

  • Waisman Center (Waisman Biomanufacturing)

  • Catapult for cell and gene therapy

  • Merck KGaA

  • Lonza Group

  • Oxford Biomedica Plc

  • WuXi AppTec

  • Charles River Laboratories International Inc.

  • Merieux Institute (ABL Inc.)

  • BioCentriq

  • Center for Commercialization of Regenerative Medicine (CCRM)

  • Fujifilm Holdings Corporation (Fujifilm Cellular Dynamics)

  • Amgen Inc.

  • Bluebird Bio Inc.

  • Takeda Pharmaceutical Company Limited

For more information on this report, please visit https://www.researchandmarkets.com/r/eq9z3d

Media contact:

Research and Markets
Laura WoodChief director
press@researchandmarkets.com

For EST office hours Call + 1-917-300-0470
For US / CAN call toll free + 1-800-526-8630
For GMT office hours Call + 353-1-416-8900

USA Fax: 646-607-1907
Fax (outside the US): + 353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

Cision

Cision

View original content: https://www.prnewswire.com/news-releases/global-cell-therapy-manufacturing-market-to-reach-6-01-billion-by-2026–301622807.html

SOURCE Research and Markets

Leave a Reply

%d bloggers like this: